Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,854,470 | 4,044,912 | 3,655,547 | 3,800,000 | 3,034,370 |
| Marketable Securities | 331,329 | 404,755 | 325,948 | 344,000 | 663,700 |
| Receivables | 3,511,394 | 3,219,273 | 3,199,749 | 3,256,000 | 3,190,010 |
| Inventories | 1,349,198 | 1,484,582 | 1,418,364 | 1,313,000 | 1,442,330 |
| Other current assets | 122,206 | 123,543 | 132,731 | 154,000 | 1,120,260 |
| TOTAL | $9,168,597 | $9,277,065 | $8,732,339 | $8,867,000 | $9,450,670 |
| Non-Current Assets | |||||
| PPE Net | 1,812,202 | 1,851,034 | 1,844,585 | 4,369,310 | N/A |
| Investments And Advances | 943,430 | 879,830 | 911,567 | 940,000 | 721,970 |
| Intangibles | 3,853,731 | 3,863,165 | 3,763,347 | 0 | 0 |
| Other Non-Current Assets | 518,329 | 596,169 | 587,667 | 4,385,001 | 3,241,690 |
| TOTAL | $7,127,692 | $7,190,198 | $7,107,166 | $9,694,311 | $3,963,660 |
| Total Assets | $16,296,280 | $16,467,260 | $15,839,500 | $16,050,000 | $15,651,750 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,936,554 | 2,043,091 | 1,816,861 | 1,816,000 | 1,149,100 |
| Other current liabilities | 1,525,401 | 1,352,890 | 1,405,683 | 1,353,000 | 2,037,520 |
| TOTAL | $3,734,975 | $3,601,008 | $3,348,650 | $3,308,000 | $3,409,350 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 462,070 | 424,810 | 429,838 | 419,000 | 638,670 |
| TOTAL | $468,468 | $432,528 | $438,334 | $426,000 | $638,670 |
| Total Liabilities | $4,203,443 | $4,033,526 | $3,786,975 | $3,734,000 | $4,048,030 |
| Shareholders' Equity | |||||
| Common Shares | 906,409 | 988,810 | 1,009,410 | 1,000,000 | 1,030,000 |
| Retained earnings | 7,839,154 | 8,448,595 | 8,276,982 | 8,396,000 | 8,928,500 |
| Other shareholders' equity | 2,309,243 | 1,865,844 | 1,612,282 | 1,731,000 | 423,010 |
| TOTAL | $12,092,840 | $12,433,740 | $12,052,530 | $12,315,000 | $11,603,720 |
| Total Liabilities And Equity | $16,296,283 | $16,467,266 | $15,839,505 | $16,049,000 | $15,651,750 |